Table 3 Hazard ratio of each metabolic phenotype for incident gastric cancer
|  | Impaired fasting plasma glucose and/or diabetes (−) | Impaired fasting plasma glucose and/or diabetes (+) |
|---|---|---|
Person-year, n | 85,934.94 | 34,455.79 |
Incident cases, n | 38 | 40 |
Incidence rate per 1000 person-years | 0.44 | 1.16 |
Crude model | Ref | 2.67 (1.71–4.17), p < 0.001 |
|  | Hypertension (−) | Hypertension (+) |
Person-year, n | 91,735.7 | 28,655 |
Incident cases, n | 46 | 32 |
Incidence rate per 1000 person-years | 0.50 | 1.12 |
Crude model | Ref | 2.28 (1.44–3.56), p < 0.001 |
|  | Elevated triglycerides (−) | Elevated triglycerides (+) |
Person-year, n | 104,572 | 15,818.4 |
Incident cases, n | 62 | 16 |
Incidence rate per 1000 person-years | 0.59 | 1.01 |
Crude model | Ref | 1.69 (0.94–2.85), p = 0.077 |
|  | Low HDL-cholesterol (−) | Low HDL-cholesterol (+) |
Person-year, n | 93,354.8 | 27,036 |
Incident cases, n | 55 | 23 |
Incidence rate per 1000 person-years | 0.59 | 0.86 |
Crude model | Ref | 1.41 (0.85–2.26), p = 0.180 |